Simris Group
0.122 SEK +1.67%Be the first to follow this company
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Read moreRevenue
4.35M
EBIT %
-842.3 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
SIMRIS B
Daily low / high price
0.115 / 0.122
SEK
Market cap
42.46M SEK
Turnover
15.55K SEK
Volume
131K
Financial calendar
Interim report
15.05.2024
General meeting
29.05.2024
Interim report
14.08.2024
Interim report
13.11.2024
Annual report
26.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 7.1 % | 7.1 % |
SIX SIS AG, W8IMY | 5.3 % | 5.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Simris Group AB (publ) announces the outcome of the directed offer of convertible debentures
SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools